Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib/II Study of Hypofractionated Radiotherapy Combined With Immunochemotherapy as Conversion Therapy for Locally Advanced Gastroesophageal Junction Adenocarcinoma

NCT07072351 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT07072351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07072351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib/II Study of Hypofractionated Radiotherapy Combined With Immunochemotherapy as Conversion Therapy for Locally Advanced Gastroesophageal Junction Adenocarcinoma
Lead sponsor
West China Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
September 15, 2025
Completion date
May 14, 2028
Enrollment
88 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy, gastroesophageal junction adenocarcinoma, hypofractionated radiotherapy, immunotherapy